Clinical Challenges in High-Risk Patient Populations with Pneumonia
Information Heading link
Speaker: Andrew Shorr, MD, MPH, MBA
Section Head of Pulmonary and Critical Care Medicine
MedStar Washington Hospital Center
Professor of Medicine
Georgetown University
Session Information Heading link
ACPE UAN# 0016-0000-21-002-L01-P, 0.5 contact hour (0.05 CEUs),
0.5 AMA PRA Category 1 Credit(s)™ CME
Learning Objectives
- Describe the clinical challenges and recognize high-risk patient populations with HABP/VABP
- Discuss the prevalence and outcomes in patients with HABP/VABP caused by multidrug-resistant Gram-negative microorganisms
Speaker Disclosures:
Dr. Shorr is a speaker for Merck and is a consultant for Entasis, Merck, Pfizer, Shionogi, and Spero.
Modified on February 18, 2021